Skip to content
healthcare.dev

Insulin Degludec

NDC 73070-503, insulin degludec, injection, solution, from Novo Nordisk Pharma, Inc..

Product NDC
73070-503
Status
Listed
Labeler
Novo Nordisk Pharma, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA203314
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73070-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN DEGLUDEC200 U/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
73070-503-15730700503153 SYRINGE, PLASTIC in 1 CARTON (73070-503-15) / 3 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c1be283d-4b1d-4996-b2a7-4488dbff3037
  • NADAC price for package 73070050315

    GET /v1/drugs/nadac/73070050315

Use it

Look up 73070-503 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73070-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73070-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.